XML 40 R24.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 9 - Segment Information (Tables)
9 Months Ended
Dec. 31, 2014
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
   

Three Months Ended December 31, 2014

 
   

Biological

Indicators

   

Instruments

   

Continuous

Monitoring

   

Total

 

Revenues

  $ 6,964     $ 8,216     $ 2,650     $ 17,830  
                                 

Gross profit

  $ 4,194     $ 5,412     $ 1,446     $ 11,052  

Selling expenses

    365       919       488       1,772  
    $ 3,829     $ 4,493     $ 958       9,280  

Reconciling items (1)

                            (5,567 )

Earnings before income taxes

                          $ 3,713  
   

Three Months Ended December 31, 2013

 
   

Biological

Indicators

   

Instruments

   

Continuous

Monitoring

   

Total

 

Revenues

  $ 5,317     $ 6,438     $ 1,361     $ 13,116  
                                 

Gross profit

  $ 2,976     $ 4,137     $ 593     $ 7,706  

Selling expenses

    404       1,047       144       1,595  
    $ 2,572     $ 3,090     $ 449       6,111  

Reconciling items (1)

                            (3,384 )

Earnings before income taxes

                          $ 2,727  
   

Nine Months Ended December 31, 2014

 
   

Biological

Indicators

   

Instruments

   

Continuous

Monitoring

   

Total

 

Revenues

  $ 19,822     $ 24,966     $ 7,982     $ 52,770  
                                 

Gross profit

  $ 12,029     $ 15,794     $ 4,057     $ 31,880  

Selling expenses

    766       3,093       1,318       5,177  
    $ 11,263     $ 12,701     $ 2,739       26,703  

Reconciling items (1)

                            (15,354 )

Earnings before income taxes

                          $ 11,349  
   

Nine Months Ended December 31, 2013

 
   

Biological

Indicators

   

Instruments

   

Continuous

Monitoring

   

Total

 

Revenues

  $ 16,181     $ 19,468     $ 1,361     $ 37,010  
                                 

Gross profit

  $ 9,019     $ 12,491     $ 593     $ 22,103  

Selling expenses

    1,350       2,603       144       4,097  
    $ 7,669     $ 9,888     $ 449       18,006  

Reconciling items (1)

                            (9,326 )

Earnings before income taxes

                          $ 8,680  
Reconciliation of Assets from Segment to Consolidated [Table Text Block]
   

December 31, 2014

   

March 31, 2014

 

Total assets

               

Biological Indicators

  $ 25,921     $ 22,771  

Instruments

    54,308       36,797  

Continuous Monitoring

    31,086       28,578  

Corporate and administrative

    4,863       9,383  
    $ 116,178     $ 97,529  
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]
   

Three Months Ended December 31,

   

Nine Months Ended December 31,

 
   

2014

   

2013

   

2014

   

2013

 

Net revenues from unaffiliated customers:

                               

United States

  $ 11,423     $ 7,054     $ 29,612     $ 20,877  

Foreign

    6,407       6,062       23,158       16,133  
    $ 17,830     $ 13,116     $ 52,770     $ 37,010